STOCKS SINK WITH FED IN FOCUS, AMAZON EARNINGS ON DECK

Pot stocks trade higher on move to reclassify marijuana in the U.S.

Amedisys, Inc. (AMED)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

92.06

+0.22

(+0.24%)

As of 03:08PM EDT. Market open.

Loading interactive chart...

Zacks
Amedisys (AMED) Q1 Earnings Surpass Estimates, Margins Rise
Amedisys (AMED) tops on revenue and earnings estimates in the first quarter of fiscal 2024.
Zacks
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics
The headline numbers for Amedisys (AMED) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks
Amedisys (AMED) Q1 Earnings and Revenues Surpass Estimates
Amedisys (AMED) delivered earnings and revenue surprises of 1.98% and 1.21%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?